KR950032169A - 안약 조성물 - Google Patents

안약 조성물 Download PDF

Info

Publication number
KR950032169A
KR950032169A KR1019950001542A KR19950001542A KR950032169A KR 950032169 A KR950032169 A KR 950032169A KR 1019950001542 A KR1019950001542 A KR 1019950001542A KR 19950001542 A KR19950001542 A KR 19950001542A KR 950032169 A KR950032169 A KR 950032169A
Authority
KR
South Korea
Prior art keywords
optionally substituted
hydrogen
compound
intraocular pressure
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019950001542A
Other languages
English (en)
Korean (ko)
Inventor
다까히로 오가와
다까아끼 데구찌
Original Assignee
요시다 쇼오지
센쥬세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼오지, 센쥬세이야꾸 가부시끼가이샤 filed Critical 요시다 쇼오지
Publication of KR950032169A publication Critical patent/KR950032169A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019950001542A 1994-01-27 1995-01-27 안약 조성물 Withdrawn KR950032169A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP94-7470 1994-01-27
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
KR950032169A true KR950032169A (ko) 1995-12-20

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950001542A Withdrawn KR950032169A (ko) 1994-01-27 1995-01-27 안약 조성물

Country Status (9)

Country Link
US (1) US5538974A (https=)
EP (1) EP0667156B1 (https=)
KR (1) KR950032169A (https=)
CN (1) CN1116928A (https=)
AT (1) ATE157870T1 (https=)
CA (1) CA2141176A1 (https=)
DE (1) DE69500660T2 (https=)
ES (1) ES2106573T3 (https=)
TW (1) TW316235B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
CN1269484C (zh) 1998-09-18 2006-08-16 艾尔科实验室公司 用于治疗青光眼的5-羟色胺激活性激动剂
US6903081B2 (en) * 2000-03-31 2005-06-07 Purdue Research Foundation Phosphoramidates and methods therefor
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
WO2003051352A1 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
PT1534391E (pt) * 2002-07-19 2007-05-31 Biovitrum Ab Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
JP2006501245A (ja) * 2002-08-30 2006-01-12 アルコン,インコーポレイテッド 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用
BR0316775A (pt) * 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
CA2536185C (en) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Drug delivery system by administrating fine particles to sub-tenon
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
TW200520760A (en) * 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) * 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US20050276867A1 (en) 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
US7425572B2 (en) * 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EP2119436A4 (en) 2006-10-20 2010-03-03 Ltd Liability Company Mitotech PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
WO2008048135A1 (fr) * 2006-10-20 2008-04-24 Limited Liability Company 'mitotechnology' Composition destinée à la régénération, la stimulation de la croissance et l'adaptation de plantes à tous types de facteurs de stress
US8349902B2 (en) 2007-01-29 2013-01-08 Mitotech Sa Pharmaceutical compositions useful for preventing and treating oncological diseases
EP2145623A4 (en) * 2007-01-29 2010-10-27 Ltd Liability Company Mitotech PHARMACEUTICAL AND COSMETIC COMPOSITIONS FOR ACCELERATING THE PROCESS OF WOUND HEALING AND OTHER SURFACE INJURIES
US8679557B2 (en) * 2007-02-27 2014-03-25 Sentiss Pharma Private Limited Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma
US9439916B2 (en) * 2007-04-11 2016-09-13 Mitotech Sa Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
CN102548548B (zh) * 2009-06-10 2017-09-01 米拓科技有限公司(卢森堡) 用于医学和兽医学的眼科药物组合物
MX2012005356A (es) 2009-11-13 2013-01-29 Obschestvo S Ogranichennoi Otvetstvennostyu Mitotekh Substancias farmaceuticas basadas en antioxidantes dirigidos a mitocondria.
US9320690B2 (en) 2010-12-20 2016-04-26 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
WO2012167236A1 (en) 2011-06-03 2012-12-06 Mitotech Sa Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
CN112439071B (zh) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (en) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin derivatives, their production and use

Also Published As

Publication number Publication date
EP0667156B1 (en) 1997-09-10
US5538974A (en) 1996-07-23
EP0667156A1 (en) 1995-08-16
ATE157870T1 (de) 1997-09-15
CA2141176A1 (en) 1995-07-28
TW316235B (https=) 1997-09-21
DE69500660D1 (de) 1997-10-16
CN1116928A (zh) 1996-02-21
DE69500660T2 (de) 1998-02-26
ES2106573T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
KR950032169A (ko) 안약 조성물
DE69332735D1 (de) Verwendung von Benzothiophene zur Behandlung von Hypercholesterolämie
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
DE122008000050I1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
KR950010886A (ko) 혈청 콜레스테롤의 강하 방법
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR950031086A (ko) 각막 장해 치료제
KR890000458A (ko) 티오펜설폰아미드 녹내장 치료제
ATE158795T1 (de) Thiazolidindionderivate, ihre herstellung und anwendung
EP0645382A4 (en) CUMARIN DERIVATIVES AND THEIR USE.
IT1196423B (it) Benzotiazolin-composti
DE69611502D1 (de) (Oxo-1-Alkyl)amino-2-desoxy-2-glucopyranosid von Dihydroxy-2,3-propyl, Verfahren zur Herstellung und ihre Verwendungen
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
ATE206050T1 (de) Okulares hypotensium
KR890006231A (ko) 상승작용을 하는 안내압 저하 조성물
KR900011764A (ko) 치환된 벤조[b]피란, 이의 제조방법, 이의 용도 및 이들 화합물을 기본으로 하는 약제학적 제제
DE68902627D1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
KR920008012A (ko) 트리아졸 유도체
KR910011851A (ko) 벤젠 축합 유도체
KR920009772A (ko) 트리아릴메탄 화합물 및 압력 민감성 기록재료
KR840001580A (ko) 6'-(2-아미노-2-〔4-아실욕시페닐〕아세트아미도페니실라노 일옥시메틸 페니실라네이트 1,1-디옥사이드 화합물의 제조방법
KR910011258A (ko) 녹내장의 치료방법
KR890005096A (ko) 빈카민산 유도체
KR890005110A (ko) 신규의 3-아로일-6,7-디히드로-5h-피롤로[1,2-c]이미다졸-7-카르복시산유도체

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19950127

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid